Medication info
Brivaracetam Tablets 25 mg

Brivaracetam Tablets 25 mg

Prescription medicationTabletOral
Ingredient · strength
Brivaracetam›25mg / 1 tablet
Manufacturer / importer
Jongkundang Co., Ltd.
Appearance
Gray oval film-coated tablets
Packaging
PTP - 30 tablets/box[(10 tablets/PTP*3)]
Approval status
Active

MFDS item code 202502513 · Approved 2025.09.23

Summary

Main use
Adjunctive treatment of partial-onset seizures in patients with epilepsy aged 16 years and older
Who takes it
Adults
Adult dose
Take this medicine twice daily. The recommended initial dose is 25mg or 50mg per dose, based on the healthcare provider’s assessment of the potential side effects in relation to seizure reduction. Based on clinical response and tolerability, the dose may be increased or decreased from 50mg per day[25mg twice daily] to 200mg per day[100mg twice daily]. This medicine is a film-coated tablet. Swallow it whole with water. It may be taken with or without food. If you miss a dose If you miss one or more doses, take one dose as soon as you remember, and then take the next dose at the next morning or evening dose time. When discontinuing treatment If you wish to stop taking this medicine, gradually reduce the dose by 50mg per day at 1-week intervals. After taking 50mg per day for 1 week, a dose of 20mg per day is recommended for the final week (see section ‘1. Warnings’). Elderly patients (65 years and older) Dose adjustment is not required for elderly patients. Clinical experience in elderly patients aged 65 years and older is limited. Renal impairment Dose adjustment is not required in patients with renal impairment. This medicine is not recommended for patients with end-stage renal disease who are receiving hemodialysis. Hepatic impairment Exposure to this medicine is increased in patients with hepatic impairment. The recommended initial dose for patients with hepatic impairment is 50mg per day[25mg twice daily], and the recommended maximum dose is 150mg per day[75mg twice daily].

Ingredients

Manufacturer
Jongkundang Co., Ltd.

Efficacy & effects

Adjunctive treatment of partial-onset seizures in patients with epilepsy aged 16 years and older

  • Secondary generalized seizures
  • partial seizures
View approved original text

This medication is used as an adjunctive therapy for the treatment of partial seizures in epilepsy patients aged 16 and older and is also effective for cases associated with secondary generalized seizures. In other words, it helps improve partial seizures or associated generalized seizures.

How to take

Adult dose

Take this medicine twice daily. The recommended initial dose is 25mg or 50mg per dose, based on the healthcare provider’s assessment of the potential side effects in relation to seizure reduction. Based on clinical response and tolerability, the dose may be increased or decreased from 50mg per day[25mg twice daily] to 200mg per day[100mg twice daily]. This medicine is a film-coated tablet. Swallow it whole with water. It may be taken with or without food. If you miss a dose If you miss one or more doses, take one dose as soon as you remember, and then take the next dose at the next morning or evening dose time. When discontinuing treatment If you wish to stop taking this medicine, gradually reduce the dose by 50mg per day at 1-week intervals. After taking 50mg per day for 1 week, a dose of 20mg per day is recommended for the final week (see section ‘1. Warnings’). Elderly patients (65 years and older) Dose adjustment is not required for elderly patients. Clinical experience in elderly patients aged 65 years and older is limited. Renal impairment Dose adjustment is not required in patients with renal impairment. This medicine is not recommended for patients with end-stage renal disease who are receiving hemodialysis. Hepatic impairment Exposure to this medicine is increased in patients with hepatic impairment. The recommended initial dose for patients with hepatic impairment is 50mg per day[25mg twice daily], and the recommended maximum dose is 150mg per day[75mg twice daily].

Precautions

This medication, as an antiepileptic drug, may induce suicidal thoughts or behaviors, so if such symptoms appear during treatment, you should consult your physician immediately. Additionally, this drug can cause central nervous system-related side effects such as drowsiness, fatigue, and dizziness, so caution is especially needed when taking it for the first time. Stopping the medication abruptly may worsen seizures, so it should be tapered off gradually according to the doctor's instructions. You should not take this medication if you have an allergy to any of its components or have specific genetic disorders like lactose intolerance. Patients with poor liver function need to adjust the dosage of this medication, so consultation with a doctor is required. Severe skin reactions such as rash or blisters can occur, so if you notice any skin changes, stop taking the medication immediately and inform healthcare professionals. This drug may interact with other antiepileptic medications, so if you are taking any other medications, be sure to inform your physician or pharmacist. Women who are pregnant or planning to become pregnant should consult a physician before taking this medication, and caution is needed for breastfeeding, as medication can be transmitted through breast milk. It is not recommended for children under 16 years, as safety and efficacy have not been established. This medication can cause drowsiness or dizziness, so be careful when driving or operating machinery. There is no specific antidote for overdose, so strictly adhere to the dosage and visit a medical institution immediately if any abnormal symptoms occur. Lastly, keep this drug out of reach of children and do not transfer it to other containers.

Side effects

  • suicidal ideation
  • suicidal behavior
  • drowsiness
  • fatigue
  • dizziness
  • coordination disorder
  • influenza
  • type 1 hypersensitivity reaction
  • neutropenia
  • decreased appetite
Show 22 more
  • depression
  • anxiety
  • irritability
  • insomnia
  • psychotic symptoms
  • aggression
  • restlessness
  • seizures
  • vertigo
  • upper respiratory infection
  • cough
  • nausea
  • vomiting
  • constipation
  • Stevens-Johnson syndrome (SJS)
  • dizziness
  • equilibrium disturbance
  • anxiety
  • hypersensitivity
  • insomnia
  • depression
  • suicidal thoughts

Not everyone experiences these, and they can vary from person to person.

Storage

This medication can be sensitive to air or moisture, so it should be stored in a tightly sealed container. It is best to maintain the storage temperature between 1 and 30 degrees Celsius at room temperature. This will help preserve the medication's effectiveness for a longer time.

Appearance and packaging

Appearance

Gray oval film-coated tablets

Package unit

PTP - 30 tablets/box[(10 tablets/PTP*3)]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.